RxDoctor Payments Data

Robert Vasquez

Pediatric Hematology-Oncology · New Orleans, LANPI 1255592374

Payments from drug & device makers

What this record shows

24 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 56.6% of the total. Reporting peaked in 2022 at $3,691 and has fallen 85.8% since, to $525 in 2025.

$5,816in general payments, 2019–2025

Across 64 payments — averaging $90.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$3K
  • Y-mabs Therapeutics, Inc.$346
  • Sobi, Inc$294
  • Seagen Inc.$236
  • Amgen$233
  • Genetix Biotherapeutics Inc$198
  • plus $1K from 18 others
$38,700in research payments, 2019–2025

Across 5 payments — averaging $7740.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$25K
  • Amgen$14K

What the payments were for

  • Consulting fees$3,18055%
  • Food & beverage$2,63645%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,816 in reported general payments places this provider in the 65th percentile of 26 pediatric hematology-oncology providers in Louisiana.

See all pediatric hematology-oncology providers in Louisiana

Other pediatric hematology-oncology in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →